Latest news and press releases about CAMP4 Therapeutics Corporation (CAMP): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Price
| Price | $3.86 |
| Market Cap | $82M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -362.08 |
| EV / EBITDA | -0.12 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -314.08% |
| Return on Invested Capital | -69.76% |
| Return on Assets | -114.79% |
| Gross Margin | 77.80% |
| Operating Margin | -1242.50% |
| Net Margin | -2543.74% |
Related companies: ACRV · ALXO · ATYR · BMEA · HYFT · PMVP · QNCX
Explore sector: Healthcare · Biotechnology
More sections of CAMP: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks